Previous studies have demonstrated that the expression of pulmonary CYR61 is increased in many inflammatory diseases, such as acute lung injury, idiopathic pulmonary fibrosis, pulmonary hypertension, and COPD (17–21, 23). Here, CCN1 is linked to pulmonary fibrosis.